Bpifrance is making a EUR95 million investment in MédiPôle Partenaires to support the company’s growth strategy.
Bpifrance is now a major shareholder in the company alongside Bridgepoint, which will remain the group's majority shareholder.
MédiPôle Partenaires was created in 2014 following the combination of MédiPôle Sud Santé and Médi‑Partenaires, and is now one of the largest private hospital groups in France. It is renowned in particular in the fields of medicine, surgery and obstetrics (MSO), post-acute care and rehabilitation, dialysis, imaging and home care. In 2015, MédiPôle Partenaires generated revenue of approximately EUR866 million.
The group offers a large range of specialties and comprises a network of 63 facilities in strategic locations, in which the group seeks to establish or strengthen its leadership positions.
MédiPôle Partenaires has a strategic focus on four major regions with dense populations: Languedoc-Roussillon Midi-Pyrénées, Aquitaine Limousin Poitou-Charentes, Provence-Alpes-Côte d‫’Azur and Nord-Pas-de Calais Picardie.
It works with approximately 2,500 practitioners and treated approximately 1,100,000 patients in 2015.
Bpifrance's investment in MédiPôle Partenaires complements the group’s already existing means to accelerate its organic and external growth by contributing to the development of its regional medical clusters, by investing in cutting-edge infrastructure and by making targeted acquisitions to consolidate the still highly fragmented private hospital market.
Prior to Bpifrance's acquisition of a stake in the group, the shareholding structure of MédiPôle Partenaires changed through the sale of Marcel Hermann's shares.
Philippe Gravier, CEO of MédiPôle Partenaires, says: "We are proud of our partnership with Bpifrance, which is making its first-ever investment in a private hospital group and thereby recognising the quality of its project and our teams. Our group can now leverage additional resources to pursue the development of its regional medical clusters that bring together innovative equipment and well-recognised medical practitioners, offering patients an integrated care pathway, from diagnosis to home care. We are well-positioned to capitalise on the consolidation of the sector and thereby strengthen our multi-regional leadership positions."
